血友病可以治愈吗? 这取决于定义
Lieke Baas1, Rieke van der Graaf1, Karina Meijer2
1Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Research and practice in thrombosis and haemostasis
|October 11, 2024
概括
定义血友病的"治疗方法"至关重要,因为像基因疗法这样的创新治疗方法正在出现. 本综述澄清了当前对血友病治愈的理解,以及它与健康和疾病概念的关系.
科学领域:
- 血液学 血液学 血液学
- 医学伦理 医学伦理
- 医学哲学 医学哲学
背景情况:
- 血友病治疗已经进步,改善了患者的寿命和生活质量.
- 目前的血友病疗法没有提供确定的治疗方法.
- 基因治疗为治愈提供了一个潜在的途径,但它的定义仍然难以捉摸.
研究的目的:
- 分析目前在血友病治疗中的"治愈"概念.
- 探索治疗的定义和血友病分类之间的关系.
- 将治疗的讨论与健康和疾病的更广泛的哲学概念联系起来.
主要方法:
- 血友病治疗和治愈定义的文献综述.
- 分析关于健康和疾病的科学和哲学话语.
- 对血友病与治疗有关的分类进行检查.
主要成果:
- 血友病的"治愈"的定义并没有得到一致的应用或明确的定义.
- 关于治愈的讨论与不断变化的血友病分类有关.
- 关于健康和疾病的哲学观点为了解血友病治愈的理解提供了信息.
结论:
- 血友病需要一个明确的,普遍接受的"治愈"定义.
- 了解"治愈"需要整合临床,伦理和哲学观点.
- 进一步的对话是必要的,以建立一个精确的血友病治愈的定义和未来的疗法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis
6.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.1K
Introduction to Hemostasis
6.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.2K
CRISPR
49.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.7K


